KCNH2 and adenocarcinoma: The analysis of the case-control study indicated a statistically significant association between BE hERG1 expression status and risk of progression to adenocarcinoma (odds ratio = 3.70, 95% CI: 1.40–9.82; P = 0.006) (Table 1).